...
首页> 外文期刊>International Journal of Research in Medical Sciences >Atypical neuroleptic malignant syndrome. ?Doing more harm than gain?
【24h】

Atypical neuroleptic malignant syndrome. ?Doing more harm than gain?

机译:非典型的神经抑制性恶性综合征。 ?做得更好的伤害?

获取原文
           

摘要

Neuroleptic malignant syndrome (NMS) a rare, idiosyncratic, and potentially fatal adverse reaction can be deceptive especially when the hallmark features are lacking. Most diagnostic criteria include fever and muscle rigidity, although NMS may present without either. Delirium, agitation and catatonia can be the earliest features of NMS and in acute care settings, concomitant use of sedatives and anti-psychotics by the attending clinicians may even obscure the sentinel signs of NMS and further aggravate the underlying insult. A strong clinical suspicion based on clinical history is crucial for early diagnosis and treatment and the strict adherence to the classical criteria of NMS may lead to a diagnostic delay and dire consequences for these patients and sometimes this delay can procure death.
机译:神经抑制的恶性综合征(NMS)罕见,特异性,潜在的致命不良反应可能是欺骗性的,特别是当缺乏标志特征时。大多数诊断标准包括发烧和肌肉刚性,尽管没有任何一种。谵妄,搅拌和强迫性可以是NMS和急性护理环境中最早的特征,伴随着参加临近临床医生的镇静剂和反精神病学甚至可能掩盖了NMS的Sentinel迹象,并进一步加剧了潜在的侮辱。基于临床历史的强烈临床怀疑对于早期诊断和治疗至关重要,严格遵守NMS的经典标准可能导致这些患者的诊断延迟和可怕后果,有时这种延迟可以采购死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号